⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 9, 2017Current Opinion in HIV and AIDS

Why a universal antiretroviral regimen?

Charles Flexner Polly Clayden François Venter

View at Publisher

Ask AI

Bookmark

Share

Abstract

TOWARDS A UNIVERSAL ANTIRETROVIRAL REGIMEN: Edited by Charles W. Flexner, Willem D.F. Venter, and Polly Clayden

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Flexner et al. (2017) studied this question.

synapsesocial.com/papers/6a9a7e91262e4da96990b0db https://doi.org/10.1097/coh.0000000000000390

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Antiretroviral Therapy for the Prevention of HIV-1 TransmissionCohort Study · 2016 · 1,696 citations
2Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practiceCohort Study · 2016 · 184 citations
3Candidates for inclusion in a universal antiretroviral regimenReview · 2017 · 14 citations
4Candidates for inclusion in a universal antiretroviral regimenHuman Clinical Trial · 2017 · 18 citations
5Candidates for inclusion in a universal antiretroviral regimenMeta-Analysis · 2017 · 33 citations

Antiretroviral dose optimization2017
Compatibility of next-generation first-line antiretrovirals with rifampicin-based antituberculosis therapy in resource limited settings2017
Toward a universal antiretroviral regimen2017
Immune cell phenotypes across tissues in people with HIVCurrent Opinion in HIV and AIDS · 2026
Central nervous system reservoirs and neuroHIV: lessons from rapid research autopsy studiesCurrent Opinion in HIV and AIDS · 2026

More from Current Opinion in HIV and AIDS

More from Johns Hopkins University

More from University of the Witwatersrand

More from Perinatal HIV Research Unit